LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Line of Laboratory Balances Focuses on Most Often Used Weighing Tasks

By LabMedica International staff writers
Posted on 08 May 2014
Image: Some examples of the new Entris line of laboratory balances (Photo courtesy of Sartorius).
Image: Some examples of the new Entris line of laboratory balances (Photo courtesy of Sartorius).
Biotech and other life science researchers can increase their productivity by selecting one or more new laboratory balances from an innovative new line.

Sartorius (Gottingen, Germany) recently introduced the new Entris, a balance that focuses on the most commonly used weighing applications and dispenses with costly additional functions.

The line of Entris balances comprised 15 analytical and precision balances that cover a weighing capacity from 60 grams to 8.2 kilograms with a readability of 0.1 milligram to 0.1 gram.

The logical key assignment on the Entris and its clearly structured user interface make daily routine weighing much easier. Most models of the new Entris family are equipped with a monolithic weighing system featuring external adjustment or an internal, motorized adjustment function. This guarantees consistently accurate weighing results, which are displayed on the easy-to-read backlit, high-contrast display.

The Entris system, which can display information in German, English, French, Italian, Spanish, Russian and Polish, is equipped with applications for density determination, animal weighing, counting, conversion, and weighing in percent. The easily removable draft shield and stainless steel parts render the Entris quick and easy to clean.

Related Links:
Sartorius
Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more